Arbutus Biopharma GAAP EPS of -$0.04 misses by $0.01, revenue of $0.53M misses by $0.42M
Source: SeekingAlpha
2025-11-13 08:04:56 ET
More on Arbutus Biopharma
- Arbutus: IP Drama With High Stakes
- Seeking Alpha’s Quant Rating on Arbutus Biopharma
- Historical earnings data for Arbutus Biopharma
- Financial information for Arbutus Biopharma
Read the full article on Seeking Alpha
For further details see:
Arbutus Biopharma GAAP EPS of -$0.04 misses by $0.01, revenue of $0.53M misses by $0.42M
Arbutus Biopharma Corporation
NASDAQ: ABUS
ABUS Trading
5.35% G/L:
$4.725 Last:
1,973,916 Volume:
$4.43 Open:
ABUS Latest News
March 03, 2026 04:15:00 pm
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna
March 03, 2026 04:15:00 pm
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
November 13, 2025 07:30:00 am
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 07, 2025 08:00:00 am
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
ABUS Stock Data
$811,607,352
153,282,242
0.14%
53
N/A
Biotechnology & Life Sciences
Healthcare
US
Warminster
